At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...
INCHEON, South Korea, Oct. 2, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that AVTOZMA ® (tocilizumab-anoh) intravenous (IV) formulation is now available to patients in the United States.
The top U.S. infectious disease medical association said on Monday that Gilead Sciences Inc's antiviral drug remdesivir should be used for hospitalized COVID-19 patients despite a World Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback